BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Treatment
27 results:

  • 1. Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model.
    Redenšek Trampuž S; van Riet S; Nordling Å; Ingelman-Sundberg M
    Sci Rep; 2024 Jan; 14(1):1396. PubMed ID: 38228622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
    Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
    J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study.
    Wang W; Lin G; Hao Y; Guan Y; Zhang Y; Xu C; Wang Q; Wang D; Jiang Z; Cai J; Lou G; Song Z; Zhang Y
    Eur J Cancer; 2022 Oct; 174():21-30. PubMed ID: 35970032
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3.
    Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
    Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
    Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study.
    Duberg AS; Lybeck C; Fält A; Montgomery S; Aleman S
    Hepatol Commun; 2022 Sep; 6(9):2418-2430. PubMed ID: 35503810
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Single cell transcriptional diversity and intercellular crosstalk of human liver cancer.
    Meng Y; Sang Y; Liao J; Zhao Q; Qu S; Li R; Jiang J; Wang M; Wang J; Wu D; Cheng C; Wei L
    Cell Death Dis; 2022 Mar; 13(3):261. PubMed ID: 35322024
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of liver Fibrosis in Severe Obesity.
    Pivovarova-Ramich O; Loske J; Hornemann S; Markova M; Seebeck N; Rosenthal A; Klauschen F; Castro JP; Buschow R; Grune T; Lange V; Rudovich N; Ouwens DM
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946738
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
    Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
    Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model.
    Liu L; Liu C; Zhao M; Zhang Q; Lu Y; Liu P; Yang H; Yang J; Chen X; Yao Y
    PLoS One; 2020; 15(12):e0243911. PubMed ID: 33326461
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes.
    Younossi ZM; Tampi RP; Nader F; Younossi IM; Cable R; Srishord M; Racila A
    Liver Int; 2020 Feb; 40(2):308-318. PubMed ID: 31705834
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma.
    Jewell ML; Gibson JR; Guy CD; Hyun J; Du K; Oh SH; Premont RT; Hsu DS; Ribar T; Gregory SG; Diehl AME
    Am J Pathol; 2020 Jan; 190(1):93-107. PubMed ID: 31669305
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
    Cao X; Xu L; Liu Q; Yang L; Li N; Li X
    Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury.
    McDaniel K; Huang L; Sato K; Wu N; Annable T; Zhou T; Ramos-Lorenzo S; Wan Y; Huang Q; Francis H; Glaser S; Tsukamoto H; Alpini G; Meng F
    J Biol Chem; 2017 Jul; 292(27):11336-11347. PubMed ID: 28536261
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC.
    Song Y; Kim JS; Choi EK; Kim J; Kim KM; Seo HR
    Oncotarget; 2017 Mar; 8(13):21650-21662. PubMed ID: 28423507
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.
    Chen JY; Newcomb B; Zhou C; Pondick JV; Ghoshal S; York SR; Motola DL; Coant N; Yi JK; Mao C; Tanabe KK; Bronova I; Berdyshev EV; Fuchs BC; Hannun Y; Chung RT; Mullen AC
    Sci Rep; 2017 Mar; 7():44867. PubMed ID: 28322247
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
    Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
    Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.